The Duke-NUS Medical School (Duke-NUS) has appointed Prof Zhang Su-Chun as Director of its Neuroscience and Behavioural Disorders (NBD) Signature Research Programme.
The Duke-NUS Medical School (Duke-NUS) has appointed Prof Zhang Su-Chun as Director of its Neuroscience and Behavioural Disorders (NBD) Signature Research Programme.
Prof Zhang is an internationally-recognised neuroscientist, known for pioneering the transformation of embryonic stem cells into neural cells, leading the way for possible future treatments of Parkinson's disease and other degenerative neurological disorders.
Prof. Zhang, who holds 17 patents, joins Duke-NUS from the Waisman Centre of the University of Wisconsin, Madison, USA, where he is the Steenbock Professor in Behavioural and Neural Sciences. His appointment takes effect on 1 March 2017.
As Director, Prof. Zhang will also work closely with Duke University in the US, and with academic and clinical partners in Singapore, such as the National Neuroscience Institute (NNI) of SingHealth, to develop next-generation approaches to probe neuronal function and improve therapies for neurological disorders.
For more information about this appointment, please visit the Duke-NUS newsroom.
